NCT05074433 · Interventional trial
A Study to Evaluate Efficacy and Safety of Casirivimab+Imdevimab (Monoclonal Antibodies) for Prevention of COVID-19 in Immunocompromised Adolescents and Adults
Overall registry status Terminated
Phase 3
Conditions Immunocompromised
Delaware Valley sites
- Penn Prevention Clinical Research Site · Philadelphia, PA · Philadelphia County
- Temple University · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory